INSAN Inc. Stock

Equities

A277410

KR7277410007

Food Processing

End-of-day quote Korea S.E. 18:00:00 2024-05-02 EDT 5-day change 1st Jan Change
1,716 KRW -0.75% Intraday chart for INSAN Inc. +0.23% -7.09%

Financials

Sales 2022 33.54B 24.75M 33.87M Sales 2023 37.3B 27.53M 37.67M Capitalization 70.46B 52M 71.16M
Net income 2022 3.78B 2.79M 3.81M Net income 2023 4.97B 3.67M 5.02M EV / Sales 2022 2.2 x
Net Debt 2022 16.34B 12.06M 16.51M Net Debt 2023 1.34B 987K 1.35M EV / Sales 2023 1.92 x
P/E ratio 2022
15.5 x
P/E ratio 2023
14.5 x
Employees 196
Yield 2022
2.25%
Yield 2023
2.71%
Free-Float 75.36%
More Fundamentals * Assessed data
Dynamic Chart
INSAN Inc. announced that it expects to receive KRW 15 billion in funding from Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Samsung Securities Co.,Ltd., Korea Investment & Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd. CI
INSAN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
INSAN Inc. announced that it has received KRW 12 billion in funding from Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd. CI
INSAN Inc. announced that it expects to receive KRW 12 billion in funding from Mirae Asset Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd. CI
INSAN Inc. announced that it expects to receive KRW 10 billion in funding from POSCO Venture Capital Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Daewoo Co., Ltd., SUSUNG ASSET MANAGEMENT Co., Ltd., KB Securities Co.,Ltd, Samsung Securities Co.,Ltd. CI
INSAN Inc. completed the acquisition of IBKS No.8 Special Purpose Acquisition Company in a reverse merger transaction. CI
INSAN Inc. signed a merger contract to acquire IBKS No.8 Special Purpose Acquisition Company in a reverse merger transaction. CI
Sungsook Woo acquired 0.6% stake in INSANGA Inc. from Seoyoung Yoo for KRW 100 million. CI
Kim, Yoonse, Woo, Sungsook and Hyun, Wansoon acquired an additional 1.1% stake in INSANGA Inc. from Yoo, Seoyoung for approximately KRW 180 million. CI
Insan Inc. announced that it has received KRW 2 billion in funding from POSCO Venture Capital Co., Ltd. CI
Insan Inc. announced that it expects to receive KRW 2 billion in funding from POSCO Venture Capital Co., Ltd. CI
INSANGA Inc. announced that it has received KRW 1.1 billion in funding from Yuanta Investment CI
INSANGA Inc. announced that it expects to receive KRW 1.1 billion in funding from Yuanta Investment CI
An unknown buyer acquired 3.3% stake in INSAN Inc. from Hosoon Yoo for KRW 500 million. CI
Yoon-se Kim and Youngran Lee acquired 3.9% stake in INSAN Inc. from Hosoon Yoo for approximately KRW 600 million. CI
More news
1 day-0.75%
1 week+0.23%
Current month-0.75%
1 month-1.55%
3 months-3.87%
6 months-16.70%
Current year-7.09%
More quotes
1 week
1 706.00
Extreme 1706
1 749.00
1 month
1 679.00
Extreme 1679
2 060.00
Current year
1 679.00
Extreme 1679
2 070.00
1 year
1 679.00
Extreme 1679
4 395.00
3 years
1 605.00
Extreme 1605
4 395.00
5 years
1 035.00
Extreme 1035
4 395.00
10 years
1 035.00
Extreme 1035
4 395.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 68 -
Director/Board Member 45 -
Director/Board Member 69 -
Members of the board TitleAgeSince
Chief Executive Officer 68 -
Director/Board Member 74 -
Director/Board Member 69 -
More insiders
Date Price Change Volume
24-05-03 1,716 -0.75% 387,339
24-05-02 1,729 0.00% 455,053
24-04-30 1,729 -0.23% 584,783
24-04-29 1,733 +1.23% 1,047,959
24-04-26 1,712 -3.33% 2,695,945

End-of-day quote Korea S.E., May 02, 2024

More quotes
INSAN Inc. formerly IBKS No.8 Special Purpose Acquisition Company, is a Korea-based company mainly engaged in the manufacture and sell of bamboo salts and bamboo salt application food. The bamboo salt products are inclusive of insan bamboo salt original, insan purple bamboo salt, daily bamboo salt and others. In addition, the Company is involved in the provision of duck extract, soy sauces, soybean pastes, red pepper pastes, as well as pills and others. The Company distributes its products within domestic market and to overseas markets, such as America, Thailand and other Asian countries.
More about the company
  1. Stock Market
  2. Equities
  3. A277410 Stock